ATE232207T1 - N-triazolyl-2-indolcarbonsäureamide und ihre verwendung als cck-a agonisten - Google Patents
N-triazolyl-2-indolcarbonsäureamide und ihre verwendung als cck-a agonistenInfo
- Publication number
- ATE232207T1 ATE232207T1 AT98924383T AT98924383T ATE232207T1 AT E232207 T1 ATE232207 T1 AT E232207T1 AT 98924383 T AT98924383 T AT 98924383T AT 98924383 T AT98924383 T AT 98924383T AT E232207 T1 ATE232207 T1 AT E232207T1
- Authority
- AT
- Austria
- Prior art keywords
- indolecarbononic
- cck
- triazolyl
- agonists
- acid amides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9705850A FR2763337B1 (fr) | 1997-05-13 | 1997-05-13 | Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant |
PCT/FR1998/000905 WO1998051686A1 (fr) | 1997-05-13 | 1998-05-06 | N-triazolyl-2-indolecarboxamides et leur utilisation comme agonistes de cck-a |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE232207T1 true ATE232207T1 (de) | 2003-02-15 |
Family
ID=9506830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98924383T ATE232207T1 (de) | 1997-05-13 | 1998-05-06 | N-triazolyl-2-indolcarbonsäureamide und ihre verwendung als cck-a agonisten |
Country Status (35)
Country | Link |
---|---|
EP (1) | EP0984960B1 (de) |
JP (1) | JP2001524980A (de) |
KR (1) | KR20010012541A (de) |
CN (1) | CN1263528A (de) |
AR (1) | AR011729A1 (de) |
AT (1) | ATE232207T1 (de) |
AU (1) | AU725530B2 (de) |
BR (1) | BR9811465A (de) |
CA (1) | CA2289573A1 (de) |
CO (1) | CO4940485A1 (de) |
CZ (1) | CZ289484B6 (de) |
DE (1) | DE69811223T2 (de) |
DK (1) | DK0984960T3 (de) |
DZ (1) | DZ2486A1 (de) |
EE (1) | EE9900524A (de) |
ES (1) | ES2190081T3 (de) |
FR (1) | FR2763337B1 (de) |
GT (1) | GT199800068A (de) |
HR (1) | HRP980258B1 (de) |
HU (1) | HUP0002763A3 (de) |
ID (1) | ID22911A (de) |
IL (1) | IL132903A0 (de) |
IS (1) | IS5235A (de) |
NO (1) | NO995513L (de) |
NZ (1) | NZ500637A (de) |
PL (1) | PL336772A1 (de) |
RU (1) | RU2175323C2 (de) |
SI (1) | SI0984960T1 (de) |
SK (1) | SK154299A3 (de) |
TR (1) | TR199902795T2 (de) |
TW (1) | TW396155B (de) |
UY (1) | UY24997A1 (de) |
WO (1) | WO1998051686A1 (de) |
YU (1) | YU57999A (de) |
ZA (1) | ZA983997B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2802530B1 (fr) * | 1999-12-17 | 2002-02-22 | Sanofi Synthelabo | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant |
KR20030042035A (ko) * | 2000-10-26 | 2003-05-27 | 사노피-신델라보 | 트리아졸 유도체 및 이들을 포함하는 제약 조성물 |
FR2815963B1 (fr) * | 2000-10-26 | 2003-02-28 | Sanofi Synthelabo | Nouveaux derives du triazole et les compositions pharmaceutiques les contenant |
HUP0004741A2 (hu) * | 2000-11-28 | 2002-12-28 | Sanofi-Synthelabo | Kémiai eljárás tiazolszármazékok előállítására és új intermedier |
US20050014805A1 (en) * | 2001-10-12 | 2005-01-20 | Chenzhi Zhang | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity |
EP1314733A1 (de) | 2001-11-22 | 2003-05-28 | Aventis Pharma Deutschland GmbH | Indol-2-carbonsäureamide als Faktor-Xa-Hemmer |
EP1479677A1 (de) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Neue Indolderivate als Faktor Xa-Inhibitoren |
EP1532980A1 (de) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-Heteroaryl Indol-Carboxamide und deren analoga zur Vewendung als glucokinase Aktivatoren zur Behandlung von Diabetes |
GB0403038D0 (en) * | 2004-02-11 | 2004-03-17 | Novartis Ag | Organic compounds |
US20100113492A1 (en) | 2007-01-26 | 2010-05-06 | Merck & Co., Inc. | Substituted Aminopyrimidines as Cholecystokinin-1 Receptor Modulators |
KR20110028661A (ko) * | 2008-07-15 | 2011-03-21 | 노파르티스 아게 | Dgat1 억제제로서의 헤테로아릴 유도체 |
BRPI1010738A8 (pt) * | 2009-06-09 | 2017-12-26 | Actelion Pharmaceuticals Ltd | Derivados de aminotriazol fluorado |
EP2490659B1 (de) * | 2009-10-22 | 2017-03-01 | Henkel AG & Co. KGaA | Mittel zur temporären verformung keratinhaltiger fasern, enthaltend eine nichtionische, mittels propylenoxid modifizierte stärke und ein chitosan |
CN106928147A (zh) * | 2017-03-14 | 2017-07-07 | 华东师范大学 | 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用 |
CN107271623A (zh) * | 2017-07-27 | 2017-10-20 | 青岛啤酒股份有限公司 | 基于人体饱腹感的啤酒可饮性评价方法 |
WO2021071837A1 (en) | 2019-10-07 | 2021-04-15 | Kallyope, Inc. | Gpr119 agonists |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2701708B1 (fr) * | 1993-02-19 | 1995-05-19 | Sanofi Elf | Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament. |
FR2703995B1 (fr) * | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant. |
-
1997
- 1997-05-13 FR FR9705850A patent/FR2763337B1/fr not_active Expired - Fee Related
-
1998
- 1998-05-06 CN CN98807175A patent/CN1263528A/zh active Pending
- 1998-05-06 AU AU76599/98A patent/AU725530B2/en not_active Ceased
- 1998-05-06 EP EP98924383A patent/EP0984960B1/de not_active Expired - Lifetime
- 1998-05-06 IL IL13290398A patent/IL132903A0/xx unknown
- 1998-05-06 EE EEP199900524A patent/EE9900524A/xx unknown
- 1998-05-06 DE DE69811223T patent/DE69811223T2/de not_active Expired - Fee Related
- 1998-05-06 CO CO98024703A patent/CO4940485A1/es unknown
- 1998-05-06 TR TR1999/02795T patent/TR199902795T2/xx unknown
- 1998-05-06 HU HU0002763A patent/HUP0002763A3/hu unknown
- 1998-05-06 NZ NZ500637A patent/NZ500637A/xx unknown
- 1998-05-06 KR KR1019997010496A patent/KR20010012541A/ko not_active Application Discontinuation
- 1998-05-06 YU YU57999A patent/YU57999A/sh unknown
- 1998-05-06 CZ CZ19994006A patent/CZ289484B6/cs not_active IP Right Cessation
- 1998-05-06 CA CA002289573A patent/CA2289573A1/fr not_active Abandoned
- 1998-05-06 SI SI9830372T patent/SI0984960T1/xx unknown
- 1998-05-06 PL PL98336772A patent/PL336772A1/xx unknown
- 1998-05-06 AT AT98924383T patent/ATE232207T1/de not_active IP Right Cessation
- 1998-05-06 DZ DZ980096A patent/DZ2486A1/xx active
- 1998-05-06 JP JP54885398A patent/JP2001524980A/ja not_active Ceased
- 1998-05-06 ES ES98924383T patent/ES2190081T3/es not_active Expired - Lifetime
- 1998-05-06 BR BR9811465-4A patent/BR9811465A/pt not_active IP Right Cessation
- 1998-05-06 DK DK98924383T patent/DK0984960T3/da active
- 1998-05-06 SK SK1542-99A patent/SK154299A3/sk unknown
- 1998-05-06 WO PCT/FR1998/000905 patent/WO1998051686A1/fr not_active Application Discontinuation
- 1998-05-06 RU RU99125773/04A patent/RU2175323C2/ru not_active IP Right Cessation
- 1998-05-06 ID IDW991374A patent/ID22911A/id unknown
- 1998-05-11 AR ARP980102152A patent/AR011729A1/es active IP Right Grant
- 1998-05-12 UY UY24997A patent/UY24997A1/es not_active IP Right Cessation
- 1998-05-12 TW TW087107326A patent/TW396155B/zh active
- 1998-05-12 ZA ZA9803997A patent/ZA983997B/xx unknown
- 1998-05-13 HR HR980258A patent/HRP980258B1/xx not_active IP Right Cessation
- 1998-05-20 GT GT199800068A patent/GT199800068A/es unknown
-
1999
- 1999-10-29 IS IS5235A patent/IS5235A/is unknown
- 1999-11-11 NO NO995513A patent/NO995513L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE202347T1 (de) | Aminothiophencarbonsäureamide und ihre verwendung als phosphodiesterase inhibitoren | |
DE59803292D1 (de) | Triazolverbindungen und deren verwendung als dopamin-d 3-liganden | |
ATE277895T1 (de) | 4-brom or 4-iod-phenylamino- benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren | |
ATE205185T1 (de) | Benzamid-derivate und deren verwendung als vasopressin-antagonisten | |
DE59712887D1 (de) | Substituierte phenylketoenole und ihre verwendung als schädlingsbekämpfungsmittel | |
ATE344246T1 (de) | Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer | |
DE69637691D1 (de) | Azeotropähnliche zusammensetzungen und ihre verwendung | |
DE69638056D1 (de) | Azeotropähnliche zusammensetzungen und ihre verwendung | |
ATE299503T1 (de) | Pyridin-3-carbonsäurederivate und ihre verwendung als zwischenprodukte | |
ATE227266T1 (de) | Aromatische c16-c20-substituierte tetrahydro- prostaglandine und ihre verwendung als prostaglandin f agonisten | |
DE59806989D1 (de) | Laseretiketten und ihre Verwendung | |
ATE232207T1 (de) | N-triazolyl-2-indolcarbonsäureamide und ihre verwendung als cck-a agonisten | |
DE59912795D1 (de) | Substituierte Benzamide und ihre Verwendung als Immunmodulatoren | |
DE59805492D1 (de) | Laseretiketten und ihre Verwendung | |
DE69806419T2 (de) | Harzzusammensetzung und ihre Verwendung | |
DE69510228T2 (de) | Piperidinessigsäurederivate und ihre verwendung als fibrinogenantagonistmittel | |
DE69811500D1 (de) | Kristallmodifikation von 1-(2,6-difluorbenzyl)-1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum | |
DE69620914D1 (de) | Perfluoralkoxycycloalkancarbonylfluorid-zusammensetzungen und ihre verwendung | |
ATE253059T1 (de) | Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer | |
DE69811018T2 (de) | Triazol-Derivate und ihre Verwendung als antimykotische Mittel | |
DE69832902D1 (de) | Oromukosal-zytokin-zusammensetzungen und ihre verwendung | |
DE59806523D1 (de) | Substituierte heterocyclische Benzocycloalkene und ihre Verwendung als analgetisch wirksame Substanzen | |
DE59605796D1 (de) | Oximether- und acrylsäurederivate und ihre verwendung als fungizide | |
DE59510203D1 (de) | Aminosäure-Derivate und ihre Verwendung als Schädlingsbekämpfungsmittel | |
DE59708683D1 (de) | Kupfer-Chrom-Titan-Silizium-Legierung und ihre Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0984960 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |